RASCHI, EMANUEL

RASCHI, EMANUEL  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Docenti di ruolo di IIa fascia  

Mostra records
Risultati 1 - 20 di 199 (tempo di esecuzione: 0.032 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-023-01391-4.pdf40264_2023_1391_MOESM1_ESM.docx
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F. 2024-01-01 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Symmetrical cutaneous rash in two women. Orioni G, Velez-Pelaez MC, Starace MVR, Tengattini V, Raschi E, La Placa M. 2024-01-01 CLINICAL CASE REPORTS - 1.01 Articolo in rivista -
Antipsychotics and Drug-Induced Liver Injury Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; ...De Ponti, Fabrizio 2023-01-01 JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY - 1.04 Replica / breve intervento (e simili) -
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E. 2023-01-01 ADDICTION - 1.01 Articolo in rivista Behavioral excess and disruptive conduct A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct.pdf
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events. Raschi E, Casula M, Cicero AFG, Corsini A, Borghi C, Catapano A. 2023-01-01 PHARMACOLOGY & THERAPEUTICS - 1.01 Articolo in rivista Raschi E_Beyond statins_Pharmacol Ther.pdf
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, ...Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco 2023-01-01 JTO CLINICAL AND RESEARCH REPORTS - 1.01 Articolo in rivista Sisi et al. JTO CCR 23.pdfSisi et al. JTO CCR supplementary 23.pdf
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians Raschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, ...Rita; Potena, Luciano 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista Raschi et al., Drug Safety Cardiotoxicity ICI 2023.pdf40264_2023_1320_MOESM1_ESM.pdf
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista -
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Pont...i F.; Pelotti S.; Poluzzi E. 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-022-01269-x.pdf40264_2022_1269_MOESM1_ESM.pdf
Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe Menniti-Ippolito, Francesca; Aiello, Eugenio; Arzenton, Elena; Assisi, Alessandro; Blaznik, Urška...; Castenmiller, Jacqueline J. M.; Crevani, Marta; de Clock, Dominique; Di Giacomo, Silvia; Emendi, Silvia; Gonella, Laura Augusta; Ippoliti, Ilaria; Lindquist, Marie; Magro, Lara; Mazzanti, Gabriela; Mores, Nadia; Moretti, Ugo; Moro, Paola Angela; Novakovic, Budimka; Raschi, Emanuel; Siksna, Inese; Valetto, Maria Rosa; Vitalone, Annabella; Vo Van Regnault, Gwenn 2023-01-01 DRUG SAFETY - 1.04 Replica / breve intervento (e simili) -
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M....; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E. 2023-01-01 PSYCHIATRY AND CLINICAL NEUROSCIENCES - 1.01 Articolo in rivista Exploring the underlying mechanisms of drug-induced impulse control disorders a pharmacovigilance-pharmacodynamic study.pdf
Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System Fusaroli M.; Simonsen A.; Borrie S.A.; Low D.M.; Parola A.; Raschi E.; Poluzzi E.; Fusaroli R. 2023-01-01 JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH - 1.01 Articolo in rivista 2022.09.05.22279609v3.full.pdf
Interpretation of Pharmacovigilance Disproportionality Analyses Khouri, Charles; Fusaroli, Michele; Salvo, Francesco; Raschi, Emanuel 2023-01-01 CLINICAL PHARMACOLOGY & THERAPEUTICS - 1.04 Replica / breve intervento (e simili) -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study Fusaroli M.; Salvo F.; Bernardeau C.; Idris M.; Dolladille C.; Pariente A.; Poluzzi E.; Raschi E....; Khouri C. 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista Fusaroli_2023.pdf40264_2023_1329_MOESM2_ESM.xlsx40264_2023_1329_MOESM1_ESM.pdf
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database Gastaldon, C; Arzenton, E; Raschi, E; Spigset, O; Papola, D; Ostuzzi, G; Moretti, U; Trifirò, G; ...Barbui, C; Schoretsanitis, G 2023-01-01 PSYCHOLOGICAL MEDICINE - 1.01 Articolo in rivista -
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors Rossi, Simone; Cani, Ilaria; Raschi, Emanuel; Comito, Francesca; Rinaldi, Rita; Ardizzoni, Andrea...; Guarino, Maria; Gelsomino, Francesco 2023-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.04 Replica / breve intervento (e simili) -
Peripheral nervous system adverse events associated with immune checkpoint inhibitors Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lambert...i G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M. 2023-01-01 JOURNAL OF NEUROLOGY - 1.01 Articolo in rivista Rossi_JN_2023.pdf
Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells Goldman, Adam; Raschi, Emanuel; Chapman, Joab; Santomasso, Bianca D.; Pasquini, Marcelo C.; Peral...es, Miguel-Angel; Shouval, Roni 2023-01-01 BLOOD - 1.01 Articolo in rivista -
Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY Raschi E.; Comito F.; Massari F.; Gelsomino F. 2023-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -